Actavis, Inc., a global integrated specialty pharmaceutical company, and Valeant Pharmaceuticals International Inc. have entered into a marketing and distribution agreement. Under the agreement Actavis exclusively to market and distribute an authorized generic of Valeant's Zovirax ointment (acyclovir five per cent) product with immediate effect.
Additionally, Valeant has granted Actavis the exclusive right to co-promote Zovirax cream (acyclovir five per cent) to obstetricians and gynaecologists in the US, and Actavis has granted Valeant the exclusive right to co-promote Actavis Specialty Brands' Cordran Tape (flurandrenolide) product in the US
Under the terms of the exclusive Zovirax ointment agreement, Valeant will supply Actavis with a generic version of Valeant's Zovirax ointment product and Actavis will market and distribute the product in the United States. Actavis will record all of the net sales of the generic ointment product and Valeant will receive a share of the economics. Other terms of the agreement have not been disclosed.
Under terms of the agreement related to the co-promotion of Zovirax cream, Actavis will utilize its existing Specialty Brands sales and marketing structure to promote the product and will receive a co-promotion fee from sales generated by prescriptions written by its defined targeted physician group. Under the terms of the Cordran Tape co-promotion agreement, Valeant will utilize its existing dermatology sales and marketing structure to promote the product, and will receive a co-promotion fee on sales. Each party will retain all rights in and to its respective products and trademarks including booking of sales. Other terms of the agreement have not been disclosed.
Zovirax cream five per cent is indicated for the treatment of recurrent herpes labialis (cold sores) in adults and adolescents (12 years of age and older). Zovirax ointment five per cent is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients.
Cordran Tape, a potent corticosteroid for topical use, is a transparent, waterproof medicated tape used to treat the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema and psoriasis.
Actavis, Inc. is focused on developing, manufacturing and distributing generic, brand and biosimilar products.
Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics.